Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 64

1.

Plasma Membrane Transporters as Biomarkers and Molecular Targets in Cholangiocarcinoma.

Marin JJG, Macias RIR, Cives-Losada C, Peleteiro-Vigil A, Herraez E, Lozano E.

Cells. 2020 Feb 21;9(2). pii: E498. doi: 10.3390/cells9020498. Review.

PMID:
32098199
2.

Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma.

Soto M, Reviejo M, Al-Abdulla R, Romero MR, Macias RIR, Boix L, Bruix J, Serrano MA, Marin JJG.

Biochim Biophys Acta Mol Basis Dis. 2020 Jan 15;1866(5):165687. doi: 10.1016/j.bbadis.2020.165687. [Epub ahead of print]

PMID:
31953214
3.

Models for Understanding Resistance to Chemotherapy in Liver Cancer.

Marin JJG, Herraez E, Lozano E, Macias RIR, Briz O.

Cancers (Basel). 2019 Oct 29;11(11). pii: E1677. doi: 10.3390/cancers11111677. Review.

4.

Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters.

Al-Abdulla R, Perez-Silva L, Lozano E, Macias RIR, Herraez E, Abad M, Segues N, Bujanda L, Briz O, Marin JJG.

Biochem Pharmacol. 2020 Jan;171:113682. doi: 10.1016/j.bcp.2019.113682. Epub 2019 Oct 24.

PMID:
31669256
5.

Hepatoprotection of Mentha aquatica L., Lavandula dentata L. and Leonurus cardiaca L.

Pereira OR, Macias RIR, Domingues MRM, Marin JJG, Cardoso SM.

Antioxidants (Basel). 2019 Aug 2;8(8). pii: E267. doi: 10.3390/antiox8080267.

6.

Cholangiocarcinoma: State-of-the-art knowledge and challenges.

Banales JM, Cardinale V, Macias RIR, Andersen JB, Braconi C, Carpino G, Alvaro D, Calvisi DF.

Liver Int. 2019 May;39 Suppl 1:5-6. doi: 10.1111/liv.14101. No abstract available.

PMID:
31111668
7.

Causes of hOCT1-Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor-Selective Gene Therapy.

Lozano E, Macias RIR, Monte MJ, Asensio M, Del Carmen S, Sanchez-Vicente L, Alonso-Peña M, Al-Abdulla R, Munoz-Garrido P, Satriano L, O'Rourke CJ, Banales JM, Avila MA, Martinez-Chantar ML, Andersen JB, Briz O, Marin JJG.

Hepatology. 2019 Oct;70(4):1246-1261. doi: 10.1002/hep.30656. Epub 2019 May 20.

PMID:
30972782
8.

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma.

Marin JJG, Cives-Losada C, Asensio M, Lozano E, Briz O, Macias RIR.

Cancers (Basel). 2019 Mar 22;11(3). pii: E407. doi: 10.3390/cancers11030407. Review.

9.

Diagnostic and prognostic biomarkers in cholangiocarcinoma.

Macias RIR, Kornek M, Rodrigues PM, Paiva NA, Castro RE, Urban S, Pereira SP, Cadamuro M, Rupp C, Loosen SH, Luedde T, Banales JM.

Liver Int. 2019 May;39 Suppl 1:108-122. doi: 10.1111/liv.14090. Review.

PMID:
30843325
10.

Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.

Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, Kohari K, Bacq Y, Bozkurt N, Brun-Furrer R, Bull L, Estiú MC, Grymowicz M, Gunaydin B, Hague WM, Haslinger C, Hu Y, Kawakita T, Kebapcilar AG, Kebapcilar L, Kondrackienė J, Koster MPH, Kowalska-Kańka A, Kupčinskas L, Lee RH, Locatelli A, Macias RIR, Marschall HU, Oudijk MA, Raz Y, Rimon E, Shan D, Shao Y, Tribe R, Tripodi V, Yayla Abide C, Yenidede I, Thornton JG, Chappell LC, Williamson C.

Lancet. 2019 Mar 2;393(10174):899-909. doi: 10.1016/S0140-6736(18)31877-4. Epub 2019 Feb 14. Erratum in: Lancet. 2019 Mar 16;393(10176):1100.

11.

Development and characterization of mouse monoclonal antibodies to eight human complement components: Analysis of reactivity with orthologs of nine mammalian genera.

Monedero M, Infantes-Lorenzo JA, Moreno I, Martín AB, Macias RIR, Toraño A, Domínguez M.

Comp Immunol Microbiol Infect Dis. 2019 Feb;62:7-12. doi: 10.1016/j.cimid.2018.11.008. Epub 2018 Nov 24.

PMID:
30711050
12.

Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib.

Al-Abdulla R, Lozano E, Macias RIR, Monte MJ, Briz O, O'Rourke CJ, Serrano MA, Banales JM, Avila MA, Martinez-Chantar ML, Geier A, Andersen JB, Marin JJG.

Br J Pharmacol. 2019 Mar;176(6):787-800. doi: 10.1111/bph.14563. Epub 2019 Feb 11.

PMID:
30592786
13.

Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.

Banales JM, Iñarrairaegui M, Arbelaiz A, Milkiewicz P, Muntané J, Muñoz-Bellvis L, La Casta A, Gonzalez LM, Arretxe E, Alonso C, Martínez-Arranz I, Lapitz A, Santos-Laso A, Avila MA, Martínez-Chantar ML, Bujanda L, Marin JJG, Sangro B, Macias RIR.

Hepatology. 2019 Aug;70(2):547-562. doi: 10.1002/hep.30319. Epub 2019 Feb 14.

14.

Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib.

Macias RIR, Sánchez-Martín A, Rodríguez-Macías G, Sánchez-Abarca LI, Lozano E, Herraez E, Odero MD, Díez-Martín JL, Marin JJG, Briz O.

Oncotarget. 2018 Jun 19;9(47):28474-28485. doi: 10.18632/oncotarget.25494. eCollection 2018 Jun 19.

15.

Role of the placenta in serum autotaxin elevation during maternal cholestasis.

Macias RIR, Matilla S, Lozano E, Estiú MC, Oude Elferink RP, Marin JJG.

Am J Physiol Gastrointest Liver Physiol. 2018 Sep 1;315(3):G399-G407. doi: 10.1152/ajpgi.00112.2018. Epub 2018 Jun 21.

16.

Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition.

Lozano E, Briz O, Macias RIR, Serrano MA, Marin JJG, Herraez E.

J Pers Med. 2018 Apr 16;8(2). pii: E14. doi: 10.3390/jpm8020014. Review.

17.

Molecular bases of the poor response of liver cancer to chemotherapy.

Marin JJG, Briz O, Herraez E, Lozano E, Asensio M, Di Giacomo S, Romero MR, Osorio-Padilla LM, Santos-Llamas AI, Serrano MA, Armengol C, Efferth T, Macias RIR.

Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):182-192. doi: 10.1016/j.clinre.2017.12.006. Epub 2018 Mar 12. Review.

PMID:
29544679
18.

Lactation during cholestasis: Role of ABC proteins in bile acid traffic across the mammary gland.

Blazquez AMG, Macias RIR, Cives-Losada C, de la Iglesia A, Marin JJG, Monte MJ.

Sci Rep. 2017 Aug 7;7(1):7475. doi: 10.1038/s41598-017-06315-8.

19.

The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma.

Macias RIR, Banales JM, Sangro B, Muntané J, Avila MA, Lozano E, Perugorria MJ, Padillo FJ, Bujanda L, Marin JJG.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1468-1477. doi: 10.1016/j.bbadis.2017.08.002. Epub 2017 Aug 4. Review.

20.

Chemoresistance and chemosensitization in cholangiocarcinoma.

Marin JJG, Lozano E, Herraez E, Asensio M, Di Giacomo S, Romero MR, Briz O, Serrano MA, Efferth T, Macias RIR.

Biochim Biophys Acta Mol Basis Dis. 2018 Apr;1864(4 Pt B):1444-1453. doi: 10.1016/j.bbadis.2017.06.005. Epub 2017 Jul 7. Review.

Supplemental Content

Loading ...
Support Center